Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 4Phase NA 2Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 2Carcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Perivascular Epithelioid Cell Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neurofibrosarcoma 1Nerve Sheath Neoplasms 1Mucositis 1Mouth Neoplasms 1Lymphoma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Histiocytoma, Angiomatoid Fibrous 1Head and Neck Neoplasms 1Granuloma, Plasma Cell 1Gliosarcoma 1Fibrosarcoma 1

Interventions

Platinum 3Magnetic Resonance Spectroscopy 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Immunoglobulin G 2Disulfides 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2pembrolizumab 1durvalumab 1atezolizumab 1Radiotherapy, Image-Guided 1Radiation 1Pilocarpine 1Nivolumab 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Carboplatin 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Oropharyngeal Neoplasms × Radiation × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡